Table 7.

Pharmacokinetics and ADMET data.

Human Intestinal Absorption (<0.25 poor, >0.80 high)	Human oral bioavailability	Caco-2 (<0.25 poor, >50 great	Blood Brain Barrier	Subcellular localization	P-glycoprotein inhibitor	P- glycoprotein substrate
0.9640	yes	0.7279	yes	mitochondria	No	no